Qin et al [18] conducted a meta- analysis and indicated that CCND1 G870A polymorphism may increase brain tumor risk, especially for gliomas, and they also suggested that more primary large scale and well-designed studies are still required to evaluate the interaction of CCND1 G870A polymorphism with brain tumor risk. The gene discussed is CCND1; the disease is central nervous system cancer.